EP2460036

BIOLITEC PHARMA & INVESTMENT
Application Number
EP10781232A
Filing Date
May 27, 2010
Status
Revoked
Feb 7, 2020
Grant Date
Jun 28, 2017
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2460036B1 was granted to Biolitec Pharma & Investment on Jun 28, 2017 following the initial filing on May 27, 2010 under the application number EP10781232A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HERAEUS QUARZGLAS & COKGMar 28, 2018 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents